Abstract
By 1990, there was a considerable body of evidence, both from randomized trials and observational studies, that breast screening by mammography in women aged 50 and over was effective in reducing mortality from the disease [1]. It appeared that physical examination provided relatively little additional benefit, while the effect of routine breast self-examination remained unclear.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. 1990. Report on a workshop of the UICC Project on evaluation of screening for cancer. Int J Cancer 46:761–769.
Tabar L, Fagerberg G, Duffy SW, Day NE. 1989. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Commun Health 43:107–114.
Andersson I, Aspegren K, Janzon L, et al. 1988. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. Br Med J 297:943–994.
Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist L-E, Somell A. 1991. Randomised study of mammography — preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treatment 18:49–56.
Nystrom L, Rutqvist LE, Wall S, et al. 1993. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341:973–978.
Nystrom L, Larsson L-G, Rutqvist L-R, et al. 1995. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. Acta Oncol 34:145–152.
U.K. Trial of Early Detection of Breast Cancer Group. 1993. Breast cancer mortality after 10 years in the U.K. trial of early detection of breast cancer. Breast 2:13–20.
Roberts MM, Alexander FE, Anderson TJ, et al. 1990. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 335:241–246.
Alexander FE, Roberts MM, Lutz W, Hepburn W. 1989. Randomisation by cluster and the problem of social bias. J Epidemiol Commun Health 43:29–36.
Ellman R, Moss SM, Coleman D, Chamberlain J. 1993. Breast self-examination programmes in the trial of early detection of breast cancer: ten year findings. Br J Cancer 68:208–212.
Alexander FE, Anderson TJ, Brown HK, et al. 1994. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 70:542–548.
Miller AB, Howe GR, Wall C. 1981. The National Study of Breast Cancer Screening. 1981. Protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin Invest Med 4:227–258.
Miller AB, Baines CJ, To T, Wall C. 1992. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 147:1459–1488.
Kopans DB, Feig SA. 1993. The Canadian National Breast Screening Study: a critical review. AJR 161:755–760.
Baines CJ. 1994. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 120:326–334.
Kopans DB. 1990. The Canadian Screening Program: A different perspective. AJR 155:748–749.
Baines CJ, Miller AB, Kopans DB, et al. 1990. Canadian Breast Screening Study: Assessment of technical quality by external review. AJR 155:734–747.
Tarone RE. 1995. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 75:997–1003.
Elwood JM, Cox B, Richardson AK. 1993. The effectiveness of breast cancer screening by mammography in younger women. On-line J Current Clin Trials 2, Doc. No. 32.
Wald NJ, Chamberlain J, Hackshaw A. 1994. European Society of Mastology Consensus Conference on Breast Cancer Screening, Paris, 4–5 February 1993: Report of the Evaluation Committee. Clin Onco 1:261–268.
Smart CR, Hendrick RE, Rutledge JH II, Smith RA. 1995. Benefit of mammography screening in women aged 40 to 49 years: current evidence from randomized controlled trials. Cancer 75:1619–1626.
Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. 1995. Effacacy of screening mammography. A meta-analysis. JAMA 273:149–154.
Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain J. 1992. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Commun Health 46:362–364.
De Koning HJ, Boer R, Warmerdam PG, et al. 1995. Quantitiative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 87:1217–1223.
Kaluzny AD, Rimer B, Harris R. 1994. The National Cancer Institute and guideline development: lessons from the breast cancer screening controversy. J Natl Cancer Inst 86:901–903.
Mettlin C, Smart CR. 1994. Breast cancer detection guidelines for women aged 40 to 49 years: rationale for the American Cancer Society reafirmation of recommendations. Cancer 44:248–255.
Chen H-H, Tabar L, Fagerberg G, Duffy S. 1995. The effect of breast screening after age 65. J Med Screening 2:10–14.
House of Commons. Health Committee. 1995. Third Report. Breast Cancer Services. Report, together with the Proceedings of the Committee. London: HMSO.
Constanza ME. 1994. The extent of breast cancer screening in older women. Cancer 74:2046–2050.
Shapiro S, Venet W, Strax P, Venet L. 1988. Periodic screening for breast cancer. In The Health Insurance Plan Project and its Sequelae, 1963–1986. Baltimore & London: Johns Hopkins University Press.
Moss SM, Coleman DA, Ellman R, et al. 1993. Interval cancers and sensitivity in the screening centres of the U.K. Trial of Early Detection of Breast Cancer. Eur J Cancer 29A(2):225–258.
Moss SM, Ellman R, Coleman D, Chamberlain J, for the United Kingdom Trial of Early Detection of Breast Cancer Group. 1994. Survival of patients with breast cancer diagnosed in the United Kingdom trial of early detection of breast cancer. J Med Screening 1:193–198.
Mittra I. 1994. Breast screening: the case for physical examination without mammography. Lancet 343:342–344.
Tabar I, Fagerberg G, Day NE, Duffy SW, Kitchin RM. 1992. Breast cancer treatment and natural history: new insights from results of screening. Lancet 339:412–414.
Hakama M, Holli K, Isola J, et al. 1995. Aggressiveness of screen-detected breast cancers. Lancet 345:221–224.
Day NE, Tabar L, Duffy SW, Chen HH. 1995. Population breast-cancer screening. Lancet 345:853.
Gastrin G, Miller AB, To T, et al. 1994. Incidence and mortality from breast cancer in the Mama Program for breast screening in Finland, 1973–1986. Cancer 73:2168–2174.
Moss SM. 1991. Case-control studies of screening. Int J Epidemiol 20:1–6.
Newcomb PA, Weiss NS, Storer BE, et al. 1991. Breast self-examination in relation to the occurrence of advanced breast cancer. J Natl Cancer Inst 83:260–265.
Muscat JE, Huncharek MS. 1991. Breast self-examination and extent of disease: a population-based study. Cancer Detect Prev 15:155–159.
Harvey BJ, Miller AB, Baines CJ, Corey PN. In preparation. A case-control study of breast self-examination (BSE) nested in the Canadian National Breast Screening Study.
Semiglazov VF, Sagaidak VN, Moiseyenko VM, Mikhaiklov EA. 1993. The Russian Federation/World Health Organisation Study. Study of the role of breast self-examination in the reduction of mortality from breast cancer. Eur J Cancer 29A: 2039–2046.
de Waard F, Kirkpatrick A, Perry NM, et al. 1994. Breast cancer screening in the framework of the Europe Against Cancer Programme. Eur J Cancer 3 (Suppl 1):3–5.
Day NE, Williams DRR, Khaw KT. 1989. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59:954–958.
Department of Health. 1992. The Health of the Nation: A Strategy for Health in England. London: Department of Health, HSMO.
Beral V, Hermon, C, Reeves G, Peto R. 1995. Sudden fall in breast cancer rates in England and Wales. Lancet 345:1642–1643.
Smigel K. 1995. Breast cancer death rates decline for white women. J Natl Cancer Inst 87(3):173.
Feuer EJ, Wun L-M. 1992. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization. Am J Epidemiol 136:1423–1436.
Woodman CB, Threlfall AG, Boggis CR, Prior P. 1995. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme’s northwestern region. Br Med J 310:224–226.
Peeters PHM, Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP. 1989. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 59:929–932.
Wald NJ, Murphy P, Major P, Parkes C, Townsend J, Frost C. 1995. UKCCR multicentre randomized controlled trial of one and two view mammography in breast cancer screening. Br Med J 311:1189–1193.
Moss SM, Michel M, Patnick J, Johns L, Blanks R, Chamberlain J. In press. Results from the NHS breast screening programme 1990–1993. J Med Screening.
Law J. 1993. Variations in individual radiation dose in a breast screening programme and consequences for the balance between associated risk and benefit. Br J Radiol 66:691–698.
Lavin MF, Bennett I, Ramsay J, Gardiner RA, et al. 1994. Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst 86:1627–1634.
Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P. 1989. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 60:781–784.
Bull AR, Campbell MJ. 1991. Assessment of the psychological impact of a breast screening programme. Br J Radiol 64:510–515.
Fraser MN, Clarke PR. 1992. Cost-effectiveness of breast cancer screening. Breast 1:169–172.
Hurley SF, Livingstone PM, Thane N, Quang L. 1994. Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia. J Epidemiol Commun Health 48:391–399.
van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas. 1993. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 29A: 1663–1668.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Moss, S.M. (1996). Advances in screening for breast cancer. In: Miller, A.B. (eds) Advances in Cancer Screening. Cancer Treatment and Research, vol 86. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1265-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1265-9_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8539-7
Online ISBN: 978-1-4613-1265-9
eBook Packages: Springer Book Archive